Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy

Autor: Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Xu, Weilai, Ma, Liya, Luo, Yingwan, Hu, Chao, Ye, Xingnong, Wei, Juying, Lou, Yinjun, Jin, Jie, Tong, Hongyan
Zdroj: In Blood Cells, Molecules and Diseases July 2019 77:88-94
Databáze: ScienceDirect